This article in the Guardian describes a DNA-based vaccine for multiple sclerosis that's gone through in human trials and "has been declared a success by doctors in America after tests on patients revealed signs that their condition had improved," according to the story. The vaccine contains DNA responsible for producing myelin, which serves to prevent the immune system from going haywire and causing MS.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.